Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med. 1992, 326 (7): 455-465.
Article
CAS
PubMed
Google Scholar
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA: Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20 (10): 1218-1249. 10.1101/gad.1415606.
Article
CAS
PubMed
Google Scholar
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin. 2009, 59 (4): 225-49. 10.3322/caac.20006.
Article
PubMed
Google Scholar
Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H: Invasion and metastasis in pancreatic cancer. Mol Cancer. 2003, 2: 14-10.1186/1476-4598-2-14.
Article
PubMed
PubMed Central
Google Scholar
McKenna S, Eatock M: The medical management of pancreatic cancer: a review. Oncologist. 2003, 8 (2): 149-160. 10.1634/theoncologist.8-2-149.
Article
CAS
PubMed
Google Scholar
Kleeff J, Reiser C, Hinz U, Bachmann J, Debus J, Jaeger D, Friess H, Buchler MW: Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007, 245 (4): 566-572. 10.1097/01.sla.0000245845.06772.7d.
Article
PubMed
PubMed Central
Google Scholar
Stoll M, Unger T: Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept. 2001, 99 (2-3): 175-182. 10.1016/S0167-0115(01)00246-4.
Article
CAS
PubMed
Google Scholar
Thomas WGMF: Molecules in Focus Angiotensin receptors: form and distribution. IJBCB. 2003, 35: 774-779.
CAS
Google Scholar
Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993, 45 (2): 205-251.
CAS
PubMed
Google Scholar
Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG: Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol. 2001, 281 (6): H2337-2365.
CAS
PubMed
Google Scholar
Fyhrquist F, Saijonmaa O: Renin-angiotensin system revisited. J Intern Med. 2008, 264 (3): 224-236. 10.1111/j.1365-2796.2008.01981.x.
Article
CAS
PubMed
Google Scholar
Hunyady L, Catt KJ: Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2006, 20 (5): 953-970. 10.1210/me.2004-0536.
Article
CAS
PubMed
Google Scholar
Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE: Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991, 88 (3): 921-933. 10.1172/JCI115395.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prowse KR, Greider CW: Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA. 1995, 92 (11): 4818-4822. 10.1073/pnas.92.11.4818.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kanehira T, Tani T, Takagi T, Nakano Y, Howard EF, Tamura M: Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. Cancer Res. 2005, 65 (17): 7660-7665.
CAS
PubMed
Google Scholar
Puolakkainen PA, Brekken RA, Muneer S, Sage EH: Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Molecular Cancer Research. 2004, 2 (4): 215-224.
CAS
PubMed
Google Scholar
Teicher BA: Tumor Models in Cancer Research. 2002, Human Press, NJ
Google Scholar
Mazzolini G, Narvaiza I, Martinez-Cruz LA, Arina A, Barajas M, Galofré JC, Qian C, Mato JM, Prieto J, Melero I: Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. Gene Therapy. 2003, 10 (13): 1067-1078. 10.1038/sj.gt.3301957.
Article
CAS
PubMed
Google Scholar
Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M: Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis. 2005, 26 (2): 271-279. 10.1093/carcin/bgh324.
Article
CAS
PubMed
Google Scholar
Cao Z, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME: Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int. 2000, 58: 2437-2451. 10.1046/j.1523-1755.2000.00427.x.
Article
CAS
PubMed
Google Scholar
Antus B, Mucsi I, Rosivall L: Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta Physiol Hung. 2000, 87 (1): 5-24. 10.1556/APhysiol.87.2000.1.2.
Article
CAS
PubMed
Google Scholar
Takagi T, Nakano Y, Takekoshi S, Inagami T, Tamura M: Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis. 2002, 23 (7): 1235-1241. 10.1093/carcin/23.7.1235.
Article
CAS
PubMed
Google Scholar
Steckelings UM, Henz BM, Wiehstutz S, Unger T, Artuc M: Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol. 2005, 153 (5): 887-893. 10.1111/j.1365-2133.2005.06806.x.
Article
CAS
PubMed
Google Scholar
Utsunomiya H, Nakamura M, Kakudo K, Inagami T, Tamura M: Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. Regul Pept. 2005, 126 (3): 155-161. 10.1016/j.regpep.2004.09.004.
Article
CAS
PubMed
Google Scholar
Ulmasov B, Xu Z, Tetri LH, Inagami T, Neuschwander-Tetri BA: Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009, 296 (2): G284-294. 10.1152/ajpgi.90409.2008.
Article
CAS
PubMed
Google Scholar
Reddy MK, Baskaran K, Molteni A: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med. 1995, 210 (3): 221-226.
Article
CAS
PubMed
Google Scholar
Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP: Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest. 1996, 98 (3): 671-679. 10.1172/JCI118838.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hii SI, Nicol DL, Gotley DC, Thompson LC, Green MK, Jonsson JR: Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Br J Cancer. 1998, 77 (6): 880-883.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prontera C, Mariani B, Rossi C, Poggi A, Rotilio D: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer. 1999, 81 (5): 761-766. 10.1002/(SICI)1097-0215(19990531)81:5<761::AID-IJC16>3.0.CO;2-1.
Article
CAS
PubMed
Google Scholar
Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H: The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res. 2001, 7 (4): 1073-1078.
CAS
PubMed
Google Scholar
Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?. Lancet. 1998, 352 (9123): 179-184. 10.1016/S0140-6736(98)03228-0.
Article
CAS
PubMed
Google Scholar
Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993, 268 (33): 24543-24546.
CAS
PubMed
Google Scholar
Ayuzawa A, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D, Tamura M: Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer letters. 2009, 280 (1): 31-37. 10.1016/j.canlet.2009.02.011.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ichiki T, Kambayashi Y, Inagami T: Differential inducibility of angiotensin II AT2 receptor between SHR and WKY vascular smooth muscle cells. Kidney Int Suppl. 1996, 55: S14-17.
CAS
PubMed
Google Scholar
Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, et al: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest. 2003, 112 (1): 67-75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F: Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res. 2005, 11 (7): 2686-2694. 10.1158/1078-0432.CCR-04-1946.
Article
CAS
PubMed
Google Scholar
Ino K, Shibata K, Kajiyama H, Yamamoto E, Nagasaka T, Nawa A, Nomura S, Kikkawa F: Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer. 2006, 94 (4): 552-560. 10.1038/sj.bjc.6602961.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA: Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg. 2008, 12 (1): 57-66. 10.1007/s11605-007-0403-9.
Article
PubMed
Google Scholar
Fujimoto Y, Sasaki T, Tsuchida A, Chayama K: Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 2001, 495 (3): 197-200. 10.1016/S0014-5793(01)02377-8.
Article
CAS
PubMed
Google Scholar
Ino K, Shibata K, Kajiyama H, Nawa A, Nomura S, Kikkawa F: Manipulating the angiotensin system--new approaches to the treatment of solid tumours. Expert Opin Biol Ther. 2006, 6 (3): 243-255. 10.1517/14712598.6.3.243.
Article
CAS
PubMed
Google Scholar
Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T: The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995, 95 (2): 651-657. 10.1172/JCI117710.
Article
CAS
PubMed
PubMed Central
Google Scholar
Munzenmaier DH, Greene AS: Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 1996, 27 (3 Pt 2): 760-765.
Article
CAS
PubMed
Google Scholar
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100 (1): 57-70. 10.1016/S0092-8674(00)81683-9.
Article
CAS
PubMed
Google Scholar
Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008, 68 (3): 918-926. 10.1158/0008-5472.CAN-07-5714.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sugimoto T, Takiguchi Y, Kurosu K, Kasahara Y, Tanabe N, Tatsumi K, Hiroshima K, Minamihisamatsu M, Miyamoto T, Kuriyama T: Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer. Oncology Report. 2005, 14: 823-830.
CAS
Google Scholar
Rosendorff C: The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol. 1996, 28 (4): 803-812. 10.1016/S0735-1097(96)00251-3.
Article
CAS
PubMed
Google Scholar
Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Butzmann U, Freeman RS, Stahl RA: Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab Invest. 2002, 82: 1305-1317.
Article
CAS
PubMed
Google Scholar
Carnovali M: The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases. Clin Ter. 2001, 152 (2): 103-106.
CAS
PubMed
Google Scholar
Miura S, Karnik SS: Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. Embo J. 2000, 19 (15): 4026-4035. 10.1093/emboj/19.15.4026.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Butzmann U, Freeman RS, Stahl RA: Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab Invest. 2002, 82 (10): 1305-1317.
Article
CAS
PubMed
Google Scholar
Xoriuchi M, Hamai M, Cui TX, Iwai M, Minokoshi Y: Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertens Res. 1999, 22 (2): 67-74. 10.1291/hypres.22.67.
Article
CAS
PubMed
Google Scholar